322 related articles for article (PubMed ID: 24782181)
1. Thymic stromal lymphopoietin, a novel proinflammatory mediator in rheumatoid arthritis that potently activates CD1c+ myeloid dendritic cells to attract and stimulate T cells.
Moret FM; Hack CE; van der Wurff-Jacobs KM; Radstake TR; Lafeber FP; van Roon JA
Arthritis Rheumatol; 2014 May; 66(5):1176-84. PubMed ID: 24782181
[TBL] [Abstract][Full Text] [Related]
2. Intra-articular CD1c-expressing myeloid dendritic cells from rheumatoid arthritis patients express a unique set of T cell-attracting chemokines and spontaneously induce Th1, Th17 and Th2 cell activity.
Moret FM; Hack CE; van der Wurff-Jacobs KM; de Jager W; Radstake TR; Lafeber FP; van Roon JA
Arthritis Res Ther; 2013 Oct; 15(5):R155. PubMed ID: 24286358
[TBL] [Abstract][Full Text] [Related]
3. Targeting CD1c-expressing classical dendritic cells to prevent thymus and activation-regulated chemokine (TARC)-mediated T-cell chemotaxis in rheumatoid arthritis.
Hillen MR; Moret FM; van der Wurff-Jacobs K; Radstake T; Hack CE; Lafeber F; van Roon J
Scand J Rheumatol; 2017 Jan; 46(1):11-16. PubMed ID: 27250804
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of abatacept in reducing synovial T cell activation by CD1c myeloid dendritic cells is overruled by the stimulatory effects of T cell-activating cytokines.
Moret FM; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Rheumatol; 2015 Mar; 67(3):637-44. PubMed ID: 25469671
[TBL] [Abstract][Full Text] [Related]
5. Synovial T cell hyporesponsiveness to myeloid dendritic cells is reversed by preventing PD-1/PD-L1 interactions.
Moret FM; van der Wurff-Jacobs KM; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Res Ther; 2014 Nov; 16(6):497. PubMed ID: 25433812
[TBL] [Abstract][Full Text] [Related]
6. Early production of thymic stromal lymphopoietin precedes infiltration of dendritic cells expressing its receptor in allergen-induced late phase cutaneous responses in atopic subjects.
Corrigan CJ; Jayaratnam A; Wang Y; Liu Y; de Waal Malefyt R; Meng Q; Kay AB; Phipps S; Lee TH; Ying S
Allergy; 2009 Jul; 64(7):1014-22. PubMed ID: 19187393
[TBL] [Abstract][Full Text] [Related]
7. Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin-mediated induction of Th2 and Th9 responses.
Froidure A; Shen C; Gras D; Van Snick J; Chanez P; Pilette C
Allergy; 2014 Aug; 69(8):1068-76. PubMed ID: 24888572
[TBL] [Abstract][Full Text] [Related]
8. Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma.
Cheng DT; Ma C; Niewoehner J; Dahl M; Tsai A; Zhang J; Gonsiorek W; Apparsundaram S; Pashine A; Ravindran P; Jung J; Hang J; Allard J; Bitter H; Tribouley C; Narula S; Wilson S; Fuentes ME
J Allergy Clin Immunol; 2013 Aug; 132(2):455-62. PubMed ID: 23810153
[TBL] [Abstract][Full Text] [Related]
9. The Additive Inflammatory In Vivo and In Vitro Effects of IL-7 and TSLP in Arthritis Underscore the Therapeutic Rationale for Dual Blockade.
Hillen MR; Hartgring SA; Willis CR; Radstake TR; Hack CE; Lafeber FP; van Roon JA
PLoS One; 2015; 10(6):e0130830. PubMed ID: 26110994
[TBL] [Abstract][Full Text] [Related]
10. Critical proinflammatory role of thymic stromal lymphopoietin and its receptor in experimental autoimmune arthritis.
Hartgring SA; Willis CR; Dean CE; Broere F; van Eden W; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Rheum; 2011 Jul; 63(7):1878-87. PubMed ID: 21391201
[TBL] [Abstract][Full Text] [Related]
11. A thymic stromal lymphopoietin-responsive dendritic cell subset mediates allergic responses in the upper airway mucosa.
Melum GR; Farkas L; Scheel C; Van Dieren B; Gran E; Liu YJ; Johansen FE; Jahnsen FL; Baekkevold ES
J Allergy Clin Immunol; 2014 Sep; 134(3):613-621.e7. PubMed ID: 24958565
[TBL] [Abstract][Full Text] [Related]
12. Myeloid dendritic cells exhibit defects in activation and function in patients with multiple sclerosis.
Haas J; Schwarz A; Korporal-Kuhnke M; Jarius S; Wildemann B
J Neuroimmunol; 2016 Dec; 301():53-60. PubMed ID: 27836182
[TBL] [Abstract][Full Text] [Related]
13. Expression and Regulation of Thymic Stromal Lymphopoietin and Thymic Stromal Lymphopoietin Receptor Heterocomplex in the Innate-Adaptive Immunity of Pediatric Asthma.
Lin SC; Cheng FY; Liu JJ; Ye YL
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670037
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide-Elicited TSLPR Expression Enriches a Functionally Discrete Subset of Human CD14
Borriello F; Iannone R; Di Somma S; Vastolo V; Petrosino G; Visconte F; Raia M; Scalia G; Loffredo S; Varricchi G; Galdiero MR; Granata F; Del Vecchio L; Portella G; Marone G
J Immunol; 2017 May; 198(9):3426-3435. PubMed ID: 28341671
[TBL] [Abstract][Full Text] [Related]
15. Myeloid dendritic cells stimulated by thymic stromal lymphopoietin promote Th2 immune responses and the pathogenesis of oral lichen planus.
Yamauchi M; Moriyama M; Hayashida JN; Maehara T; Ishiguro N; Kubota K; Furukawa S; Ohta M; Sakamoto M; Tanaka A; Nakamura S
PLoS One; 2017; 12(3):e0173017. PubMed ID: 28278185
[TBL] [Abstract][Full Text] [Related]
16. Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis.
Reynolds G; Gibbon JR; Pratt AG; Wood MJ; Coady D; Raftery G; Lorenzi AR; Gray A; Filer A; Buckley CD; Haniffa MA; Isaacs JD; Hilkens CM
Ann Rheum Dis; 2016 May; 75(5):899-907. PubMed ID: 25923217
[TBL] [Abstract][Full Text] [Related]
17. Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles.
Lebre MC; Jongbloed SL; Tas SW; Smeets TJ; McInnes IB; Tak PP
Am J Pathol; 2008 Apr; 172(4):940-50. PubMed ID: 18292234
[TBL] [Abstract][Full Text] [Related]
18. Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus.
Hanabuchi S; Ito T; Park WR; Watanabe N; Shaw JL; Roman E; Arima K; Wang YH; Voo KS; Cao W; Liu YJ
J Immunol; 2010 Mar; 184(6):2999-3007. PubMed ID: 20173030
[TBL] [Abstract][Full Text] [Related]
19. ASP7266, a Novel Antibody against Human Thymic Stromal Lymphopoietin Receptor for the Treatment of Allergic Diseases.
Numazaki M; Abe M; Hanaoka K; Imamura E; Maeda M; Kimura A; Miyanohara J; Saito T; Arai K; Suzuki H; Saita Y
J Pharmacol Exp Ther; 2022 Jan; 380(1):26-33. PubMed ID: 34728559
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the TSLP-TSLPR-LAP signaling between epithelial and dendritic cells through hyperlipidemia contributes to regulatory T-Cell defects in atherosclerotic mice.
Yu K; Dong Q; Mao X; Meng K; Zhao X; Ji Q; Wu B; Zhong Y; Zhu Z; Liu Y; Zhang W; Tony H; Shi H; Zeng Q
Atherosclerosis; 2015 Feb; 238(2):278-88. PubMed ID: 25544178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
